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Objectives: Data on regional differences in the management of abdom-
inal aortic aneurysms (AAAs) are limited. Regional variation in patient selection
and treatment type could identify targets for quality improvement initiatives.
We used the Society for Vascular Surgery Vascular Quality Initiative to evaluate
regional variation in patient characteristics and management of AAAs.
Methods: We identiﬁed all patients undergoing open AAA repair
(OAR) or endovascular AAA repair (EVAR) in the Vascular Quality Initia-
tive from 2009 to 2012. All regional quality groups were deidentiﬁed. All
regional groups with <50 OAR were excluded, leaving seven out of 14 re-
gions. Groups were compared for patient selection and operative approach
using c2 test.
Results: A total of 8740 patients were identiﬁed: 6608 EVAR (76%)
and 2132 OAR (24%). Nine percent (range, 5%-13%) of cases were
ruptured AAAs. Most were male (78.1%; range, 73%-83%) and aged >65
years (83.2%; range, 82%-85%). The mean diameter for elective repair was
similar for EVAR (56.5; range, 56-60 mm) and OAR (59.4; range, 56-62
mm). Substantial variation by region was seen in patient selection, including
proportions of patients with congestive heart failure, hemodialysis, and oc-
togenarians. The treatment method for intact and ruptured AAA varied by
region. Elective AAA repair was performed in patients with <5 cm AAA
diameter in 14% (range, 10%-21%) of EVAR and in 13% (range, 5%-21%)
of OAR. Signiﬁcant regional differences in EVAR technique (eg, proportion
receiving general anesthesia, hypogastric coiling), OAR technique (eg, pro-
portion anterior approach and femoral anastomosis), and postoperative care
(eg, acetylsalicylic acid/statin at discharge) are reported in the Table.
Conclusion: This ﬁrst investigation of a prospective national clinical
database demonstrates signiﬁcant regional variation in the management of
AAAs. We have identiﬁed opportunities for regional quality improvement
efforts. Combining these data with outcomes data will validate previously
identiﬁed best practices and identify additional areas for regional quality
improvement.Fig. Survival of endovascular vs open repair abdominal aortic aneurysm
(AAA), all ages.
Table. Regional differences
Preoperative characteristics Min, % Max, %
Age $80 years 21 28
Congestive heart failure 6 19
Dialysis 1 3
Preoperative
Acetylsalicylic acid/statin 70 86
b-Blocker in OAR 52 80
Stress test not done in OAR 43 67
Stress test not done in EVAR 33 69
Patient selection
Unﬁt for OAR 7 23
EVAR (vs OAR) for rupture 40 59
EVAR (vs OAR) for elective repair 57 89
>5 cm for elective AAA for men 71 82
>5 cm for elective AAA for women 64 83
Treatment
General anesthesia in EVAR 80 97
Pre-op or intra-op hypogastric coil in EVAR 6 10
Anterior approach in elective OAR 40 96
General and epidural in elective OAR 11 63
Femoral anastomosis in OAR 5 21
Tube graft in OAR 34 55
ASA and statin at discharge 44 74
ASA, Acetylsalicylic acid; EVAR, endovascular aneurysm repair; OAR, open
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Objectives: Randomized controlled trials have demonstrated a signif-
icant reduction in perioperative morbidity and mortality for endovascular
aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA) relative to
open surgical repair. There are concerns, however, that the survival beneﬁt
may not be sustained due to late rupture and reintervention after EVAR.
Methods: We compared perioperative and long-term survival, reinter-
ventions, and complications after EVAR and open repair of AAA in propen-
sity score-matched cohorts of Medicare beneﬁciaries undergoing repair from
2001 to 2008 with up to 8 years of follow-up through 2009. We evaluated
perioperative and 2-year outcomes to detect trends over time.
Results: We studied 79,960 matched Medicare beneﬁciaries. Periop-
erative mortality was 1.6% for EVAR and 5.3% for open repair (P < .001).
Survival was signiﬁcantly better after EVAR for 3 years, after which conﬁ-
dence intervals overlapped and survival was similar through 8 years (Fig).
Restricted mean survival (area under the curve) analysis showed a prolonged
survival beneﬁt with EVAR lasting at least 6 years. At 8 years, rupture was
seen in 5.3% of patients after EVAR and in 1.5% after open repair (P <
.001). Reinterventions related to AAA were more common in the EVAR
group (18.1% vs 3.8%, P < .001) but were offset by a higher rate of laparot-
omy-related complications in the open repair group (17.5% vs 8.3%, P <
.001). From 2001 to 2007, perioperative mortality with EVAR decreased
from 2.1% to 1.3% (P ¼ .002), conversion to open repair dropped from
2.0% to 0.4% (P < .001), 2-year mortality after EVAR decreased from
15.8% to 13.7% (P < .001), and reinterventions at 2 years after EVAR
decreased from 9.9% to 8.5% (P < .001).
Conclusions: Compared with open repair, EVAR has a signiﬁcant sur-
vival advantage that persists for at least 3 years and equivalent late survival
through 8 years. Late rupture after EVAR is a concern that merits further
long-term follow-up. EVAR outcomes, including perioperative mortality, conver-
sion to open repair, late mortality, and reintervention, are improving over time.Disclosures: M. L. Schermerhorn: ConsultantdEndologix; D. B. Buck:
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